XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Note 5 - Stock-based Compensation
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

5.

STOCK-BASED COMPENSATION

 

At September 30, 2023, we have two stock-based compensation plans in effect. We record compensation cost related to unvested stock awards by recognizing the unamortized grant date fair value on a straight-line basis over the vesting periods of each award. We have estimated forfeiture rates based on our historical experience. Stock option compensation expense for the three and nine month periods ended September 30, 2023 and 2022 has been recognized as a component of general and administrative expenses in the accompanying Consolidated Financial Statements. We recorded $0 of stock-based compensation expense for the three months ended September 30, 2023 and 2022 and $150,000 and $160,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

 

As of September 30, 2023, there is no unrecognized compensation cost related to stock options. There were no options exercised during the three and nine months ended September 30, 2023. No options expired unexercised during the quarter. The following table summarizes options as of September 30, 2023:

 

Options Outstanding and Exercisable:

                         

Range of
Exercise Price

   

Number
Outstanding

   

Wgt. Avg. Contractual
Life Remaining (in years)

   

Wgt. Avg.
Exercise Price

   

Aggregate
Intrinsic Value

 

$3.50

- $3.86       13,000       3.5     $ 3.75     $ 211,260  
  $7.80         8,000       4.7     $ 7.80     $ 97,600  
  $19.99         30,000       5.3     $ 19.99     $ 300  
  $39.11         8,000       5.7     $ 39.11     $  

$3.50

- $39.11       59,000       4.9     $ 17.35     $ 309,160  

 

The estimated fair value of options granted is calculated using the Black-Scholes option pricing model with assumptions as previously disclosed in our 2022 Form 10-K.

 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the company’s closing stock price on the last trading day of the third quarter of 2023 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2023. The amount of aggregate intrinsic value will change based on the market value of the company’s stock.